• 52,754+ CME Conference Registrations Sold
  • 158,262+ Medical Conferences
  • 285 Specialties
  • 11,425 Organizers
  • 157,177 Speakers
  • 159 Countries
  • 4,803 Cities
Home  >  Conferences  >  Novel Antibody Therapeutics Congress

Novel Antibody Therapeutics Congress

Oct 10 - 11, 2019   |   London, England  United Kingdom
Organized by : Global Engage Ltd
Specialties : Oncology   |   Immunotherapies
Conference Brochure

Novel Antibody Therapeutics Congress is organized by Global Engage Ltd and will be held from Oct 10 - 11, 2019 at London Heathrow Marriott Hotel, London, England, United Kingdom.

Designed for experts in pharma and academia, this conference will explore the latest advances in antibody-based therapeutics in oncology. Talks will review the recent developments in bispecific antibody technology, as well as exploring the potential of new antibody and antibody-mimicking formats. A dedicated checkpoint blockades session will also examine new approaches in neutralizing cancer cell immune blockades, including advances in PD1, PD-L1, and CTLA4 targeting therapeutics, and the discovery and targeting of new biomarkers.

With recent breakthroughs in immunotherapeutics, biotherapeutics are set to lead the way in oncology in the coming years. As one of the dominant biologic formats, monoclonal antibodies stand ready to capitalize on this, building on two decades offered of exciting advancements in the treatment of cancer.

The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors, and businesses.

Antibodies for Oncology:
• Reviewing antibody discovery and engineering techniques for next-generation therapeutics
• Techniques for designing bispecific antibodies
• Approaches for ensuring specificity
• Advancing T-Cell engager therapies
• Other approaches to protein construction (DARPIN, heavy and light chain fusion, etc.)
• The potential of bispecific antibody treatments for solid tumor cancers

Immuno-oncology formats:
• Engineering novel antibody formats (TCR mimics, antibody fragments, and more)
• Challenges in constructing antibodies targeting tumor inhibitory checkpoints
• Identifying new checkpoint biomarkers
• Successes in inhibiting PD-1, PDL-1, and CTLA4
• Exploring the role of combination therapies
• Approaches to enhancing the efficacy

Additional details will be posted as soon as they are available.

View All Speaking

Christian Breunig
Christian Breunig


Rene Hoet
Rene Hoet

Immunology and Microbiology

Nicolas Poirier
Nicolas Poirier

Immunology and Microbiology

Conference Details

Scientific Poster : View Poster
Session Brochure : Download Session Brochure
Session url : Click here
Social Media Info :  

Registration Desk

Contact No. : +44 (0)1865 849 841
+44 (0)1865 849841
+44 (0) 1865 379865

View Expired Tickets
view all
  • Drive Walk Transit Bicycle

Venue Address

London Heathrow Marriott Hotel
Bath Road Heathrow Airport, Hayes
London, England, United Kingdom

Plan Your Travel

Please Rate this Conference


Reviews Given by People

No Reviews available. Be the first to write a review.

Hotels Near Venue

Stoke Place-Part of the Cairn Collection
7 miles from venue
, Free Wifi
Price : USD 102.41 Per Night
The Pinewood Hotel
5.94 miles from venue
, Free Wifi
Price : USD 90.69 Per Night
Great Fosters -Near Windsor
5.34 miles from venue
, Free Wifi
Price : USD 565.93 Per Night
Flower Pot Hotel
4.9 miles from venue
, Free Wifi
Price : USD 106.72 Per Night

Session Details

Session Topic Start Time End Time Location Speakers

Workshop Details

Title Start Time End Time Workshop Fee

Subscribe to our Newsletter


Subscribe to our newsletter and receive updates on medical conferences, board review courses and news